Assignee
ERLANDER MARK G
US·4 granted patents·6 pending applications·10 citations·filing 2003–2012
Top patents by PatentIndex Score
10 records- 0189US9447470B2Tumor grading and cancer prognosisERLANDER MARK G·Filed 2010·Granted Sep 20, 2016·8 cites·9 claims
- 0274US8435739B2Gene expression profiling from FFPE samplesERLANDER MARK G·Filed 2012·Granted May 7, 2013·0 cites·20 claims
- 0373US9856533B2Predicting breast cancer treatment outcomeERLANDER MARK G·Filed 2004·Granted Jan 2, 2018·2 cites·9 claims
- 0470US2009270271A13' Biased Detection of Nucleic AcidsERLANDER MARK G·Filed 2008·Application pending·0 cites
- 0567US8895269B2Gene expression profiling from FFPE samplesERLANDER MARK G·Filed 2011·Granted Nov 25, 2014·0 cites·17 claims
- 0666US2012322113A1Nucleic acid amplificationERLANDER MARK G·Filed 2012·Application pending·0 cites
- 0761US2011086394A1Nucleic Acid AmplificationERLANDER MARK G·Filed 2010·Application pending·0 cites
- 0854US2012329097A1Nucleic acid amplificationERLANDER MARK G·Filed 2012·Application pending·0 cites
- 0952US2005208500A1Signatures of ER status in breast cancerERLANDER MARK G·Filed 2004·Application pending·0 cites
- 1052US2006246434A1Nucleic acid amplificationERLANDER MARK G·Filed 2003·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →